Skip to main content
Clinical Trials/NL-OMON47013
NL-OMON47013
Recruiting
Phase 2

Smartphone based Monitoring and cognition Modification Against Recurrence of Depression - SMARD

Radboud Universitair Medisch Centrum0 sites224 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
224
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a patient must meet all of the following criteria:
  • \- recurrent MDD diagnoses (assessed using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM\-IV) (SCID) \[First 1996])
  • \- at least 3 previous MDD\-episodes (as assessed with the SCID\-interview)
  • \- a 17\-item Hamilton Depression Rating Scale (HDRS17\) \<\=10 \[Hamilton 1967], not fulfilling the criteria for a current MDD episode (as assessed with the SCID\-interview)
  • \- having a stable remission (\>\=8 weeks)
  • \- age 18\-65 years
  • \- in possession of smartphone and experienced in use thereof
  • For the focus\-groups in WP1, assessment of unipolarity, number of recurrences and non\-depressed state will be assessed by history only (no SCID/HDRS17\) as more thorough assessments are not proportional to the aim of the focus\-groups.

Exclusion Criteria

  • For both WPs:
  • \- diagnosis of bipolar, primary psychotic or borderline personality disorder or strong suspicion of this type of disorder
  • \- primary diagnosis of substance use or anxiety disorder with secondary MDD (comorbid secondary anxiety disorder allowed for participation)
  • \- electroconvulsive therapy within two months before inclusion
  • \- average alcohol intake of \>3 units/day
  • \- daily use of benzodiazepines (\>\=5mg diazepam or equivalent)
  • \- Incompatible smartphone to install BeHapp ;Additional exclusion\-criteria for WP2:
  • \- ongoing psychotherapy during the CCT/ABM training
  • \- previous CCT/ABM ;For the add\-on MRI\-part of WP2, standard MRI exclusion criteria will apply:
  • \- Metal objects in the body

Outcomes

Primary Outcomes

Not specified

Similar Trials